Recommendations for kidney disease guideline updating: A report by the KDIGO Methods Committee

Katrin Uhlig; Jeffrey S. Berns; Serena Carville; Wiley Chan; Michael Cheung; Gordon H. Guyatt; Allyson Hart; Sandra Zelman Lewis; Marcello Tonelli; Angela C. Webster; Timothy J. Wilt; Bertram L. Kasiske

doi:10.1016/j.kint.2015.11.030

Recommendations for kidney disease guideline updating: A report by the KDIGO Methods Committee

Katrin Uhlig, Jeffrey S. Berns, Serena Carville, Wiley Chan, Michael Cheung, Gordon H. Guyatt, Allyson Hart, Sandra Zelman Lewis, Marcello Tonelli, Angela C. Webster, Timothy J. Wilt, Bertram L. Kasiske

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Updating rather than de novo guideline development now accounts for the majority of guideline activities for many guideline development organizations, including Kidney Disease: Improving Global Outcomes (KDIGO), an international kidney disease guideline development entity that has produced guidelines on kidney diseases since 2008. Increasingly, guideline developers are moving away from updating at fixed intervals in favor of more flexible approaches that use periodic expert assessment of guideline currency (with or without an updated systematic review) to determine the need for updating. Determining the need for guideline updating in an efficient, transparent, and timely manner is challenging, and updating of systematic reviews and guidelines is labor intensive. Ideally, guidelines should be updated dynamically when new evidence indicates a need for a substantive change in the guideline based on a priori criteria. This dynamic updating (sometimes referred to as a living guideline model) can be facilitated with the use of integrated electronic platforms that allow updating of specific recommendations. This report summarizes consensus-based recommendations from a panel of guideline methodology professionals on how to keep KDIGO guidelines up to date.

Original language	English (US)
Pages (from-to)	753-760
Number of pages	8
Journal	Kidney international
Volume	89
Issue number	4
DOIs	https://doi.org/10.1016/j.kint.2015.11.030
State	Published - Apr 1 2016

Bibliographical note

Funding Information:
JSB declared having served on the clinical trial Executive Committee for Amgen; he is presently President of the National Kidney Foundation (NKF) and former NKF Vice-Chair for Clinical Practice Guidelines and Commentaries. SC acknowledged that the National Clinical Guideline Center receives funding from NICE to develop NICE clinical guidelines and reported no additional relevant financial disclosures. WC was formerly Director, Guidelines and Evidence-Based Medicine, and internal medicine physician at Northwest Kaiser Permanente, and reported no additional relevant financial disclosures. SZL is Chief Guidelines Officer at Doctor Evidence. MT is Chair of the Canadian Task Force on Preventive Health Care and reported no additional relevant financial disclosures. TJW declared having received funding from KDIGO to conduct an evidence synthesis report in support of a clinical practice guideline related to living kidney donation. BLK is immediate past KDIGO Co-Chair and reported no additional relevant financial disclosures. KU, MC, GHG, AH, and ACW reported no relevant disclosures.

Publisher Copyright:
© 2016 International Society of Nephrology.

Keywords

clinical practice guideline
guideline development
guideline updating
nephrology
systematic reviews

Publisher link

10.1016/j.kint.2015.11.030

http://europepmc.org/articles/pmc5547823

Find It

Find It at U of M Libraries

Cite this

@article{79496de9f9d5444f85c4b0c0354f0f71,

title = "Recommendations for kidney disease guideline updating: A report by the KDIGO Methods Committee",

abstract = "Updating rather than de novo guideline development now accounts for the majority of guideline activities for many guideline development organizations, including Kidney Disease: Improving Global Outcomes (KDIGO), an international kidney disease guideline development entity that has produced guidelines on kidney diseases since 2008. Increasingly, guideline developers are moving away from updating at fixed intervals in favor of more flexible approaches that use periodic expert assessment of guideline currency (with or without an updated systematic review) to determine the need for updating. Determining the need for guideline updating in an efficient, transparent, and timely manner is challenging, and updating of systematic reviews and guidelines is labor intensive. Ideally, guidelines should be updated dynamically when new evidence indicates a need for a substantive change in the guideline based on a priori criteria. This dynamic updating (sometimes referred to as a living guideline model) can be facilitated with the use of integrated electronic platforms that allow updating of specific recommendations. This report summarizes consensus-based recommendations from a panel of guideline methodology professionals on how to keep KDIGO guidelines up to date.",

keywords = "clinical practice guideline, guideline development, guideline updating, nephrology, systematic reviews",

author = "Katrin Uhlig and Berns, {Jeffrey S.} and Serena Carville and Wiley Chan and Michael Cheung and Guyatt, {Gordon H.} and Allyson Hart and Lewis, {Sandra Zelman} and Marcello Tonelli and Webster, {Angela C.} and Wilt, {Timothy J.} and Kasiske, {Bertram L.}",

note = "Funding Information: JSB declared having served on the clinical trial Executive Committee for Amgen; he is presently President of the National Kidney Foundation (NKF) and former NKF Vice-Chair for Clinical Practice Guidelines and Commentaries. SC acknowledged that the National Clinical Guideline Center receives funding from NICE to develop NICE clinical guidelines and reported no additional relevant financial disclosures. WC was formerly Director, Guidelines and Evidence-Based Medicine, and internal medicine physician at Northwest Kaiser Permanente, and reported no additional relevant financial disclosures. SZL is Chief Guidelines Officer at Doctor Evidence. MT is Chair of the Canadian Task Force on Preventive Health Care and reported no additional relevant financial disclosures. TJW declared having received funding from KDIGO to conduct an evidence synthesis report in support of a clinical practice guideline related to living kidney donation. BLK is immediate past KDIGO Co-Chair and reported no additional relevant financial disclosures. KU, MC, GHG, AH, and ACW reported no relevant disclosures. Publisher Copyright: {\textcopyright} 2016 International Society of Nephrology.",

year = "2016",

month = apr,

day = "1",

doi = "10.1016/j.kint.2015.11.030",

language = "English (US)",

volume = "89",

pages = "753--760",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "4",

}

TY - JOUR

T1 - Recommendations for kidney disease guideline updating

T2 - A report by the KDIGO Methods Committee

AU - Uhlig, Katrin

AU - Berns, Jeffrey S.

AU - Carville, Serena

AU - Chan, Wiley

AU - Cheung, Michael

AU - Guyatt, Gordon H.

AU - Hart, Allyson

AU - Lewis, Sandra Zelman

AU - Tonelli, Marcello

AU - Webster, Angela C.

AU - Wilt, Timothy J.

AU - Kasiske, Bertram L.

N1 - Funding Information: JSB declared having served on the clinical trial Executive Committee for Amgen; he is presently President of the National Kidney Foundation (NKF) and former NKF Vice-Chair for Clinical Practice Guidelines and Commentaries. SC acknowledged that the National Clinical Guideline Center receives funding from NICE to develop NICE clinical guidelines and reported no additional relevant financial disclosures. WC was formerly Director, Guidelines and Evidence-Based Medicine, and internal medicine physician at Northwest Kaiser Permanente, and reported no additional relevant financial disclosures. SZL is Chief Guidelines Officer at Doctor Evidence. MT is Chair of the Canadian Task Force on Preventive Health Care and reported no additional relevant financial disclosures. TJW declared having received funding from KDIGO to conduct an evidence synthesis report in support of a clinical practice guideline related to living kidney donation. BLK is immediate past KDIGO Co-Chair and reported no additional relevant financial disclosures. KU, MC, GHG, AH, and ACW reported no relevant disclosures. Publisher Copyright: © 2016 International Society of Nephrology.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Updating rather than de novo guideline development now accounts for the majority of guideline activities for many guideline development organizations, including Kidney Disease: Improving Global Outcomes (KDIGO), an international kidney disease guideline development entity that has produced guidelines on kidney diseases since 2008. Increasingly, guideline developers are moving away from updating at fixed intervals in favor of more flexible approaches that use periodic expert assessment of guideline currency (with or without an updated systematic review) to determine the need for updating. Determining the need for guideline updating in an efficient, transparent, and timely manner is challenging, and updating of systematic reviews and guidelines is labor intensive. Ideally, guidelines should be updated dynamically when new evidence indicates a need for a substantive change in the guideline based on a priori criteria. This dynamic updating (sometimes referred to as a living guideline model) can be facilitated with the use of integrated electronic platforms that allow updating of specific recommendations. This report summarizes consensus-based recommendations from a panel of guideline methodology professionals on how to keep KDIGO guidelines up to date.

AB - Updating rather than de novo guideline development now accounts for the majority of guideline activities for many guideline development organizations, including Kidney Disease: Improving Global Outcomes (KDIGO), an international kidney disease guideline development entity that has produced guidelines on kidney diseases since 2008. Increasingly, guideline developers are moving away from updating at fixed intervals in favor of more flexible approaches that use periodic expert assessment of guideline currency (with or without an updated systematic review) to determine the need for updating. Determining the need for guideline updating in an efficient, transparent, and timely manner is challenging, and updating of systematic reviews and guidelines is labor intensive. Ideally, guidelines should be updated dynamically when new evidence indicates a need for a substantive change in the guideline based on a priori criteria. This dynamic updating (sometimes referred to as a living guideline model) can be facilitated with the use of integrated electronic platforms that allow updating of specific recommendations. This report summarizes consensus-based recommendations from a panel of guideline methodology professionals on how to keep KDIGO guidelines up to date.

KW - clinical practice guideline

KW - guideline development

KW - guideline updating

KW - nephrology

KW - systematic reviews

UR - http://www.scopus.com/inward/record.url?scp=84964690573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964690573&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2015.11.030

DO - 10.1016/j.kint.2015.11.030

M3 - Article

C2 - 26994574

AN - SCOPUS:84964690573

SN - 0085-2538

VL - 89

SP - 753

EP - 760

JO - Kidney International

JF - Kidney International

IS - 4

ER -

Recommendations for kidney disease guideline updating: A report by the KDIGO Methods Committee

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this